Fulcrum Therapeutics Inc (FULC)

SG&A Expenses

$30.40M

TTM · Period ending: · USD

FULC logo

FULC SG&A Expenses

Latest reported$30.40M
FULC TTM SG&A Expenses ($8.31M → $30.40M)
High-resolution chart · PNG

FULC sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Fulcrum Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
30,403,000
29,769,000
28,666,000
29,105,000
29,967,000
33,386,000
36,448,000
38,088,000
39,625,000
39,701,000
41,160,000
41,934,000
41,680,000
42,455,000
41,694,000
41,269,000
40,190,000
35,777,000
30,516,000
26,678,000
23,362,000
21,826,000
21,392,000
19,928,000
18,126,000
15,611,000
13,145,000
11,133,000
9,748,000
9,175,000
8,314,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.